FyMed, Inc.

Press Releases
precision medicine

FyMed Expands Its Discovery and Drug Development Plans Through Innovative Strategies in Precision Medicine

FyMed, Inc. today announced strategic and operational expansion plans following the successful completion of major preclinical drug studies utilizing innovative companion diagnostic and prognostic technologies in precision medicine.
Read More...

FyMed Announces Notice of Allowance for US Patent Covering Fy10 Technology Platform

FyMed Inc., a specialty pharmaceutical company focused on the development and commercialization of novel therapeutics announced that its application covering the Fy10 technology platform was allowed for issuance as a new patent by the USPTO. Read More...

Early Release: FyMed Gets Patent for Novel Immunomodulatory Drug

Pharmaceutical firm FyMed Inc. has received a patent for a novel immunomodulatory drug used in the treatment of autoimmune diseases.
Read More...

FyMed Reinforces Its Drug Development Pipeline With Novel Strategies in Precision Medicine

FyMed, Inc., a pharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in precision medicine. Read More...